Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepadetox is a proprietary polyherbal formulation developed by Natural Solutions, currently in the preclinical stage of development. It is designed to treat and manage a broad spectrum of liver diseases, including hepatotoxicity, hepatic fibrosis, fatty liver (steatosis), hepatitis, and liver cirrhosis. As a polyherbal product, it likely utilizes the synergistic effects of multiple botanical extracts to provide hepatoprotective, anti-inflammatory, and antioxidant benefits. The formulation aims to stabilize hepatic cell membranes, reduce oxidative stress, and potentially inhibit the activation of hepatic stellate cells to prevent or reverse fibrosis, thereby promoting overall liver regeneration and health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hepadetox.